References

AAFP (American Academy of Family Physicians). 2006a. Board of Directors Report V to the 2006 Congress of Delegates. Leawood, KS: AAFP. http://www.aafp.org/online/etc/medialib/aafp_org/documents/about/congress/2006/bd-rpts/brdrptv.Par.0001.File.tmp/Board%20Report%20V%20on%20AAFP%20and%20Nondues%20Revenue.pdf (accessed April 8, 2009).

AAFP. 2006b. Full Disclosure for CME Activities: American Family Physician authors. Leawood, KS: AAFP. http://www.aafp.org/online/etc/medialib/aafp_org/documents/news_pubs/afp/afpconflictofinterestform.Par.0001.File.tmp/COI-form-2008.pdf (accessed August 12, 2008).

AAMC (Association of American Medical Colleges). 1998. Guidelines for Dealing with Faculty Conflicts of Commitment and Conflicts of Interest in Research. Adopted by AAMC Executive Council, February 1990; revised, January 1998. Washington, DC: AAMC.

AAMC. 2001. Protecting Subjects, Preserving Trust, Promoting Progress: Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research. Washington, DC: AAMC. http://www.aamc.org/research/coi/firstreport.pdf (accessed June 23, 2008).

AAMC. 2002. Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution’s Financial Interests in Human Subjects Research. Washington, DC: AAMC. http://www.aamc.org/research/coi/2002coireport.pdf (accessed September 19, 2008).

AAMC. 2004. Clinical Trial Contracts: A Discussion of Four Selected Provisions. Washington, DC: AAMC. https://services.aamc.org/Publications/showfile.cfm?file=version6.pdf&prd_id=76&prv_id=75&pdf_id=6 (accessed February 21, 2009).

AAMC. 2008a. Table 3: applicants to U.S. medical schools by state of legal residence, 1997-2008. In AAMC Facts. Washington, DC: AAMC. http://www.aamc.org/data/facts/2008/2008slr.htm (accessed March 22, 2009).

AAMC. 2008b. Compact Between Biomedical Graduate Students and Their Research Advisors. Washington, DC: AAMC. https://services.aamc.org/Publications/showfile.cfm?file=version127.pdf (accessed February 18, 2009).

AAMC. 2008c. Industry Funding of Medical Education. Washington, DC: AAMC. https://services.aamc.org/Publications/showfile.cfm?file=version114.pdf&prd_id=232 (accessed October 10, 2008).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 240
References AAFP (American Academy of Family Physicians). 2006a. Board of Directors Report V to the 006 Congress of Delegates. Leawood, KS: AAFP. http://www.aafp.org/online/etc/ medialib/aafp_org/documents/about/congress/2006/bd-rpts/brdrptv.Par.0001.File.tmp/ Board%20Report%20V%20on%20AAFP%20and%20Nondues%20Revenue.pdf (ac- cessed April 8, 2009). AAFP. 2006b. Full Disclosure for CME Actiities: American Family Physician authors. Leawood, KS: AAFP. http://www.aafp.org/online/etc/medialib/aafp_org/documents/ news_pubs/afp/afpconflictofinterestform.Par.0001.File.tmp/COI-form-2008.pdf (accessed August 12, 2008). AAMC (Association of American Medical Colleges). 1998. Guidelines for Dealing with Fac- ulty Conflicts of Commitment and Conflicts of Interest in Research. Adopted by AAMC Executive Council, February 1990; revised, January 1998. Washington, DC: AAMC. AAMC. 2001. Protecting Subjects, Presering Trust, Promoting Progress: Policy and Guide- lines for the Oersight of Indiidual Financial Interests in Human Subjects Research. Washington, DC: AAMC. http://www.aamc.org/research/coi/firstreport.pdf (accessed June 23, 2008). AAMC. 2002. Protecting Subjects, Presering Trust, Promoting Progress II: Principles and Recommendations for Oersight of an Institution’s Financial Interests in Human Subjects Research. Washington, DC: AAMC. http://www.aamc.org/research/coi/2002coireport. pdf (accessed September 19, 2008). AAMC. 2004. Clinical Trial Contracts: A Discussion of Four Selected Proisions. Wash- ington, DC: AAMC. https://services.aamc.org/Publications/showfile.cfm?file=version6. pdf&prd_id=76&prv_id=75&pdf_id=6 (accessed February 21, 2009). AAMC. 2008a. Table 3: applicants to U.S. medical schools by state of legal residence, 1997- 2008. In AAMC Facts. Washington, DC: AAMC. http://www.aamc.org/data/facts/2008/ 2008slr.htm (accessed March 22, 2009). AAMC. 2008b. Compact Between Biomedical Graduate Students and Their Research Adi- sors. Washington, DC: AAMC. https://services.aamc.org/Publications/showfile.cfm?file= version127.pdf (accessed February 18, 2009). AAMC. 2008c. Industry Funding of Medical Education. Washington, DC: AAMC. https:// services.aamc.org/Publications/showfile.cfm?file=version114.pdf&prd_id=232 (accessed October 10, 2008). 0

OCR for page 240
 REFERENCES AAMC. 2008d. Medical Schools. Washington, DC: AAMC. http://www.aamc.org/ medicalschools.htm (accessed November 17, 2008). AAMC. 2008e. Table 26: total active enrollment by U.S. medical school and sex, 2003-2008. In AAMC Facts. Washington, DC: AAMC. http://www.aamc.org/data/facts/2008/school- enrll0308.htm (accessed March 4, 2009). AAMC-AAU (Association of American Universities). 2008. Protecting Patients, Presering Integrity, Adancing Health: Accelerating the Implementation of COI Policies in Hu- man Subjects Research. Report of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Human Subjects Research. Washington, DC: AAMC. https:// services.aamc.org/Publications/showfile.cfm?file=version107.pdf&prd_id=220&prv_ id=268&pdf_id=107 (accessed September 19, 2008). AAU. 2001. Report on Indiidual and Institutional Financial Conflict of Interest. Report of the AAU Task Force on Research Accountability. Washington, DC: AAU. http://www. aau.edu/research/COI.01.pdf (accessed August 1, 2008). AAUP (American Association of University Professors). 2004. Statement on Corporate Fund- ing of Academic Research. Washington, DC: AAUP. http://www.aaup.org/NR/rdonlyres/ 7B12F7B9-FA00-44DD-999F-FFA21AAE1F39/0/CorporateFundingonAcaResearch.pdf (accessed April 17, 2009). AAUP/ACE (American Council on Education). 1965. On preventing conflicts of interest in government-sponsored research at universities; a joint statement of the Council of the American Association of University Professors and The American Council on Education. AAUP Bulletin 51:42-43. ABIM (American Board of Internal Medicine) Foundation, ACP-ASIM (American College of Physicians-American Society of Internal Medicine) Foundation, and European Federation of Internal Medicine. 2002. Medical professionalism in the new millennium: a physician charter. Annals of Internal Medicine 136(3):243-246. ABMS (American Board of Medical Specialties). 2007. American Board of Medical Special- ties Board Certification Editorial Background. Evanston, IL: ABMS. http://www.abms. org/news_and_events/media_newsroom/pdf/abms_editorialbackground.pdf (accessed September 25, 2008). ACC/AHA (American College of Cardiology/American Heart Association). 2009. Methodol- ogy Manual for ACC/AHA Guideline Writing Committees. Report of the ACC/AHA Task Force on Practice Guidelines. Washington, DC: ACC/AHA. http://www.acc.org/ qualityandscience/clinical/manual/pdfs/methodology.pdf (accessed April 8, 2009). ACCME (Accreditation Council for Continuing Medical Education). 2005. ACCME’s Glossary of Terms and Abbreiations. Chicago, IL: ACCME. http://cores33webs.mede.uic.edu/ capp/public/public_docs/accme_glossary_of_terms.pdf (accessed October 22, 2008). ACCME. 2008a. ACCME Annual Report Data 00. Chicago, IL: ACCME. http://www. accme.org/dir_docs/doc_upload/207fa8e2-bdbe-47f8-9b65-52477f9faade_uploaddocu- ment.pdf (accessed October 22, 2008). ACCME. 2008b. Accredited CME Is Education That Matters to Patient Care. Chicago, IL: ACCME. http://www.accme.org/dir_docs/doc_upload/d6b96a50-084c-485b-b71a- 6b405b9c07d8_uploaddocument.pdf (accessed December 30, 2008). ACCME. 2008c. Executie Summary of the Noember 00 Meetings of the ACCME Board of Directors. Chicago, IL: ACCME. http://www.accme.org/dir_docs/whats_new/607a2906- dda2-4e9d-b6cf-7922723b46a1_uploadfile.pdf (accessed February 22, 2009). ACCME. 2008d. For Comment: ACCME Proposes Additional Features of Independence in Accredited Continuing Medical Education. Chicago, IL: ACCME. http://www.accme. org/dir_docs/doc_upload/d64b68f6-9525-43af-9074-719f92ad7c97_uploaddocument. pdf (accessed October 7, 2008).

OCR for page 240
 CONFLICT OF INTEREST ACCME. 2009. List of Accredited Proiders. Chicago, IL: ACCME. http://www.accme.org/ index.cfm/fa/home.popular/popular_id/66be063a-8081-40f2-9615-042a733485d8.cfm (accessed March 23, 2009). ACE (American Council on Education). 2007. Working Paper on Conflict of Interest. Wash- ington, DC: ACE. http://www.acenet.edu/AM/Template.cfm?Section=Home&TEMPLAT E=/CM/ContentDisplay.cfm&CONTENTID=26137 (accessed April 17, 2009). ACGME (Accreditation Council for Graduate Medical Education). 2002. Principles to Guide the Relationship Between Graduate Medical Education and Industry. Chicago, IL: ACGME. http://www.acgme.org/acWebsite/positionPapers/pp_GMEGuide.pdf (accessed August 12, 2008). ACGME. 2007a. ACGME Institutional Requirements. Chicago, IL: ACGME. http://www. acgme.org/acWebsite/irc/irc_IRCpr07012007.pdf (accessed September 3, 2008). ACGME. 2007b. The ACGME at a Glance. Chicago, IL: ACGME. http://www.acgme.org/ac- Website/newsRoom/newsRm_acGlance.asp (accessed September 3, 2008). ACGME. 2008. Glossary of Terms. Chicago, IL: ACGME. http://www.acgme.org/acwebsite/ about/ab_acgmeglossary.pdf (accessed August 12, 2008). ACIP (Advisory Committee on Immunization Practices). 2007. Recommended adult im- munization schedule: United States, October 2007-September 2008. Annals of Internal Medicine 147(10):725-729. ACN (American College of Neuropsychopharmacology). 2004. Executive summary. In Pre- liminary Report of the Task Force on SSRIs and Suicidal Behaior in Youth. Nashville, TN: ACN. http://www.acnp.org/asset.axd?id=aad01592-01b2-4672-ad28-119537460ffa (accessed December 15, 2008). ACR (American College of Radiology). 2007a. ACR Practice Guideline for the Performance of Total Body Irradiation. Reston, VA: ACR. ACR (American College of Rheumatology). 2007b. Code of Ethics of the American College of Rheumatology, Inc. http://www.rheumatology.org/about/codeofethics/index.pdf (accessed September 2, 2008). Adair, R. F., and L. R. Holmgren. 2005. Do drug samples influence resident prescribing behav - ior? A randomized trial. American Journal of Medicine 118(8):881-884. AdvaMed (Advanced Medical Technology Association). 2008. Code of Ethics on Interactions with Health Care Professionals. Effective July 1, 2009. Washington, DC: AdvaMed. http://www.advamed.org/NR/rdonlyres/61D30455-F7E9-4081-B219-12D6CE347585/0/ AdvaMedCodeofEthicsRevisedandRestatedEffective20090701.pdf (accessed February 9, 2009). AFMI (Annals of Family Medicine, Inc.). 2008. Annals of Family Medicine Manuscript Agreement. Leawood, KS: AFMI. http://www.annfammed.org/misc/pdfsanddocs/ ManuscriptAgreement08.doc (accessed December 30, 2008). AGREE (Appraisal of Guidelines Research and Evaluation) Collaboration. 2003. AGREE Instrument Training Manual. http://www.agreecollaboration.org/pdf/aitraining.pdf (ac- cessed February 23, 2009). AHRP (Alliance for Human Research Protection). 2006. Vioxx Redux: FDA on the Sidelines as Marketing Subsumes Eidence: Suriing Sepsis-NEJM. New York, NY: AHRP. http:// www.ahrp.org/cms/index2.php?option=com_content&do_pdf=1&id=366 (accessed April 25, 2008). AJN (American Journal of Nephrology). 2008. Guidelines for Authors. http://content.karger. com/ProdukteDB/produkte.asp?Aktion=JournalGuidelines&ProduktNr=223979 (ac- cessed September 15, 2008). Alpert, J. S., S. Furman, and L. Smaha. 2002. Conflicts of interest: science, money, and health. Archies of Internal Medicine 162(6):635-637.

OCR for page 240
 REFERENCES AMA (American Medical Association). 2002. Opinion E-.06: Clarifying Addendum [to Opinion .06, “Gifts to physicians from industry”]. Chicago, IL: AMA. http://www. ama-assn.org/ama/pub/category/4263.html (accessed September 2, 2008). AMA. 2006. The Physician’s Recognition Award and Credit System: Information for Accred- ited Proiders and Physicians. Chicago, IL: AMA. http://www.ama-assn.org/ama1/pub/ upload/mm/455/pra2006.pdf (accessed September 15, 2008). AMA. 2007. Opinion 8.047: industry representatives in clinical settings. Code of Medi- cal Ethics. http://www.ama-assn.org/ama1/pub/upload/mm/Code_of_Med_Eth/opinion/ opinion8047.html (accessed April 8, 2009). AMA. 2008a. Continuing medical education for licensure reregistration. In State Medical Licensure Requirements and Statistics 00. Chicago, IL: AMA. http://www.ama-assn. org/ama1/pub/upload/mm/40/table16-2009.pdf (accessed February 10, 2009) AMA. 2008b. Guidance on New Procedures for CME. Chicago, IL: AMA. http://www. ama-assn.org/ama/pub/education-careers/continuing-medical-education/physicians- recognition-award-credit-system/cme-help/guidance-new-procedure-cme.shtml (accessed February 16, 2009). AMA. 2008c. Reference Committee Highlights: 00 Annual Meeting for the AMA House of Delegates. Chicago, IL: AMA. http://www.ama-assn.org/ama1/pub/upload/mm/471/ refcomhighlights.pdf (accessed January 29, 2009). AMSA (American Medical Student Association). 2008a. Focus on Pharm Free. Reston, VA: AMSA. http://www.amsa.org/prof/focus.cfm (accessed August 1, 2008). AMSA. 2008b. PharmFree Scorecard 00. Reston, VA: AMSA. http://amsascorecard.org/ (accessed September 19, 2008). Ancker, J. S., and A. Flanagin. 2007. A comparison of conflict of interest policies at peer- reviewed journals in different scientific disciplines. Science and Engineering Ethics 13(2):147-157. Andersen, M., J. Kragstrup, and J. Sondergaard. 2006. How conducting a clinical trial affects physicians’ guideline adherence and drug preferences. Journal of the American Medical Association 295(23):2759-2764. Angel, J. E. 2003. Industry sponsorship of continuing medical education. Journal of the Ameri- can Medical Association 290(9):1149-1150; author reply 1150. APA (American Psychiatric Association). 2008. Minutes. APA Board of Trustees meeting, Arlington, VA, March 9-10. Arlington, VA: APA. Arenberg, D. 2007. Bronchioloalveolar lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132(3 Suppl.):306S-313S. Armon, C., C. E. Argoff, J. Samuels, and M. M. Backonja. 2007. Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurol- ogy 68(10):723-729. Armstrong, D. 2005. Surgery journal threatens ban for authors’ hidden conflicts. Wall Street Journal, December 28, B1. Armstrong, D. 2006. Medical reviews face criticism over lapses. Wall Street Journal, July 19, B1, B2. Arnau, J. M., A. Vallano, A. Lopez, F. Pellise, M. J. Delgado, and N. Prat. 2006. A critical review of guidelines for low back pain treatment. European Spine Journal 15(5):543-553. ASCO (American Society of Clinical Oncology). 2007. Journal of Clinical Oncology Au- thor Disclosure Declaration. Alexandria, VA: ASCO. http://jco.ascopubs.org/misc/jco_ disclosure_contribution.pdf (accessed November 11, 2008). ASCO. 2008. American Society of Clinical Oncology Guideline Procedures Manual. Al- exandria, VA: ASCO. http://www.asco.org/ASCO/Quality+Care+%26+Guidelines/ Practice+Guidelines/development+process (accessed February 27, 2009).

OCR for page 240
 CONFLICT OF INTEREST ASH (American Society of Hematology). 2008. Principles, policies, and procedures related to conflict-of-interest. Written statement given to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC. The Associated Press. 2008. Medical Experts Fight Drug Industry Influence. http://www.ctv. ca/servlet/ArticleNews/story/CTVNews/20080911/medical_schools_080911/20080911? hub=Health (accessed December 15, 2008). ATS (American Thoracic Society). 2008. Policy on Management of Conflict of Interest in Official ATS Documents, Projects, and Conferences. New York, NY: ATS. http://www. thoracic.org/sections/about-ats/coi-management/resources/coi-policy.pdf (accessed August 19, 2008). AUTM (Association of University Technology Managers). 2007. AUTM U.S. Licensing Actiity Sur- ey: FY006. Deerfield, IL: AUTM. http://www.autm.net/Content/NavigationMenu/Surveys/ LicensingSurveysAUTM/FY2006LicensingActivitySurvey/AUTM_06_US_LSS_FNL.pdf (ac- cessed January 10, 2009). Avorn, J. 2006. Dangerous deception—hiding the evidence of adverse drug effects. New Eng- land Journal of Medicine 355(21):2169-2171. Avorn, J., and S. B. Soumerai. 1983. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing.” New England Journal of Medicine 308(24):1457-1463. Ayanian, J. Z., M. B. Landrum, S. L. Normand, E. Guadagnoli, and B. J. McNeil. 1998. Rating the appropriateness of coronary angiography—do practicing physicians agree with an expert panel and with each other? New England Journal of Medicine 338(26):1896-1904. Ayres, C. G., and H. M. Griffith. 2007. Perceived barriers to and facilitators of the implemen- tation of priority clinical preventive services guidelines. American Journal of Managed Care 13(3):150-155. Bahtsevani, C., G. Uden, and A. Willman. 2004. Outcomes of evidence-based clinical practice guidelines: a systematic review. International Journal of Technology Assessment in Health Care 20(4):427-433. Bailey, R. 2008. Scrutinizing Industry-Funded Science: The Crusade Against Conflicts of Interest. New York: American Council on Science and Health. http://www.acsh.org/ docLib/20080401_scrutinizing.pdf (accessed October 10, 2008). Barnes, B. E., J. G. Cole, C. T. King, R. Zukowski, T. Allgier-Baker, D. M. Rubio, and L. E. Thorndyke. 2007. A risk stratification tool to assess commercial influences on continuing medical education. Journal of Continuing Education in the Health Profes- sions 27(4):234-240. Barnes, D. E., and L. A. Bero. 1998. Why review articles on the health effects of pas - sive smoking reach different conclusions. Journal of the American Medical Association 279(19):1566-1570. Baru, J. S., D. A. Bloom, K. Muraszko, and C. E. Koop. 2001. John Holter’s shunt. Journal of the American College of Surgeons 192(1):79-85. Battista, R. N., and M. J. Hodge. 1995. Setting priorities and selecting topics for clinical prac- tice guidelines. Canadian Medical Association Journal 153(9):1233-1237. Baumann, M. H., S. Z. Lewis, and D. Gutterman. 2007. ACCP evidence-based guideline de- velopment: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Chest 132(3):1015-1024. Baxter, P. 2006. Medicine and the pharmaceutical industry. Deelopmental Medicine and Child Neurology 48(8):627. Beauchamp, T. L., and J. F. Childress. 2009. Principles of Biomedical Ethics, 6th ed. New York: Oxford University Press.

OCR for page 240
 REFERENCES Bekelman, J. E., Y. Li, and C. P. Gross. 2003. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. Journal of the American Medical Association 289(4):454-465. Bellin, M., S. McCarthy, L. Drevlow, and C. Pierach. 2004. Medical students’ exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Academic Medicine 79(11):1041-1045. Benet, L. Z. 2008. Perspectives on financial relationships and conflicts of interest in basic and early stage translational research: reflections on 28 years of organized COI experience at UCSF. Presentation to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Bennett, C. L., M. R. Somerfield, D. G. Pfister, C. Tomori, S. Yakren, and P. B. Bach. 2003. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. Journal of Clinical Oncology 21(5):937-941. Bennett, K. J., D. L. Sackett, R. B. Haynes, V. R. Neufeld, P. Tugwell, and R. Roberts. 1987. A controlled trial of teaching critical appraisal of the clinical literature to medical students. Journal of the American Medical Association 257(18):2451-2454. Benz, E. 2008. Untitled. Presentation to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Bero, L. 2008. “Experimental” institutional models for corporate funding of academic re- search: unknown effects on the research enterprise. Journal of Clinical Epidemiology 61(7):629-633. Bero, L., and D. Rennie. 1996. Influences on the quality of published drug studies. Interna- tional Journal of Technology Assessment in Health Care 12(2):209-237. Bero, L., A. Galbraith, and D. Rennie. 1992. The publication of sponsored symposiums in medical journals. New England Journal of Medicine 327(16):1135-1140. Bero, L., S. Glantz, and M. K. Hong. 2005. The limits of competing interest disclosures. Tobacco Control 14(2):118-126. Bero, L., F. Oostvogel, P. Bacchetti, and K. Lee. 2007. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Medicine 4(6):e184. Berwick, D. M. 1998. Developing and testing changes in delivery of care. Annals of Internal Medicine 128(8):651-656. Bhargava, N., J. Qureshi, and N. Vakil. 2007. Funding source and conflict of interest disclo- sures by authors and editors in gastroenterology specialty journals. American Journal of Gastroenterology 102(6):1146-1150. Bimber, B. 1996. The Politics of Expertise in Congress: The Rise and Fall of the Office of Technology Assessment. Albany, NY: State University of New York Press. Bird, S. J., and R. E. Spier. 2005. The complexity of competing and conflicting interests. Sci- ence and Engineering Ethics 11(4):515-517. Blake, R. L., Jr., and E. K. Early. 1995. Patients’ attitudes about gifts to physicians from phar- maceutical companies. Journal of the American Board of Family Practice 8(6):457-464. Blumenthal, D. 2004. Doctors and drug companies. New England Journal of Medicine 351(18):1885-1890. Blumenthal, D., E. G. Campbell, N. Causino, and K. S. Louis. 1996a. Participation of life- science faculty in research relationships with industry. New England Journal of Medicine 335(23):1734-1739. Blumenthal, D., N. Causino, E. Campbell, and K. S. Louis. 1996b. Relationships between academic institutions and industry in the life sciences—an industry survey. New England Journal of Medicine 334(6):368-373.

OCR for page 240
6 CONFLICT OF INTEREST Blumenthal, D., E. G. Campbell, M. S. Anderson, N. Causino, and K. S. Louis. 1997. With- holding research results in academic life science. Evidence from a national survey of faculty. Journal of the American Medical Association 277(15):1224-1228. Bodenheimer, T. 2000. Uneasy alliance—clinical investigators and the pharmaceutical industry. New England Journal of Medicine 342(20):1539-1544. Bodenheimer, T., R. A. Berenson, and P. Rudolf. 2007. The primary care-specialty income gap: why it matters. Annals of Internal Medicine 146(4):301-306. Bok, D. 2003. Uniersities in the Marketplace. Princeton, NJ: Princeton University Press. Boltri, J. M., E. R. Gordon, and R. L. Vogel. 2002. Effect of antihypertensive samples on physician prescribing patterns. Family Medicine 34(10):729-731. Boluyt, N., C. R. Lincke, and M. Offringa. 2005. Quality of evidence-based pediatric guide- lines. Pediatrics 115(5):1378-1391. Bombardier, C., L. Laine, A. Reicin, D. Shapiro, R. Burgos-Vargas, B. Davis, R. Day, et al. 2000. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in pa- tients with rheumatoid arthritis. VIGOR Study Group. New England Journal of Medicine 343(21):1520-1528, 2 p following 1528. Bond, E. C., and S. Glynn. 1995. Recent trends in support for biomedical research and devel- opment. In Sources of Medical Technology: Uniersities and Industry. Washington, DC: National Academy Press. Borgert, C. J. 2007. Conflict of interest or contravention of science? Regulatory Toxicology and Pharmacology 48(1):4-5. Borie, D. C., J. J. O’Shea, and P. S. Changelian. 2004. JAK3 inhibition, a viable new modal- ity of immunosuppression for solid organ transplants. Trends in Molecular Medicine 10(11):532-541. Bossuyt, P. M., J. B. Reitsma, D. E. Bruns, C. A. Gatsonis, P. P. Glasziou, L. M. Irwig, J. G. Lijmer, et al. 2003. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clinical Chemistry 49(1):1-6. Boston University. 2007. Policies for Interactions Among Clinicians at Boston Medical Center and Boston Uniersity School of Medicine and Representaties of the Healthcare Indus- try. Boston, MA: Boston University, http://www.bu.edu/cms/www.bumc.bu.edu/busm- od/files/Images/Policies/BMC-BUSM%20Industry%20Interactions%20_July%2026_.pdf (accessed September 25, 2008). Bowman, M. A. 1986. The impact of drug company funding on the content of continuing med- ical education. Journal of Continuing Education in the Health Professions 6(1):66-69. Bowman, M. A., and D. L. Pearle. 1988. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. Journal of Continuing Education in the Health Professions 8(1):13-20. Boyd, E. A. 2008. Individual and organizational financial relationships with industry: what do we know? Presentation to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Boyd, E. A., and L. A. Bero. 2000. Assessing faculty financial relationships with industry: a case study. Journal of the American Medical Association 284(17):2209-2214. Boyd, E. A., and L. A. Bero. 2006. Improving the use of research evidence in guideline develop- ment. 4. Managing conflicts of interests. Health Research Policy and Systems 4:16. Boyd, E. A., and L. A. Bero. 2007. Defining financial conflicts and managing research rela- tionships: an analysis of university conflict of interest committee decisions. Science and Engineering Ethics 13(4):415-435. Boyd, E. A., M. K. Cho, and L. A. Bero. 2003. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Academic Medicine 78(8):769-774.

OCR for page 240
 REFERENCES Boyd, E. A., S. Lipton, and L. A. Bero. 2004. Implementation of financial disclosure policies to manage conflicts of interest. Health Affairs 23(2):206-214. Brandeis, L. D. 1914. What publicity can do. In Other People’s Money and How the Bankers Use It. New York: Frederick A Stokes Company. Braunwald, E., A. S. Fauci, D. Kasper, S. Hauser, D. Longo, and J. L. Jameson. 2001. Harri- son’s Principles of Internal Medicine, vol. 2. New York: McGraw-Hill Professional. Bravo, N. R. 2008. Director’s Column: Managing Financial Conflicts of Interests. Bethesda, MD: Office of Extramural News, National Institutes of Health. http://nexus.od.nih.gov/ nexus/nexus.aspx?ID=81&Month=6&Year=2008 (accessed December 2, 2008). Brennan, T. A., and M. M. Mello. 2007. Sunshine laws and the pharmaceutical industry. Journal of the American Medical Association 297(11):1255-1257. Brennan, T. A., D. J. Rothman, L. Blank, D. Blumenthal, S. C. Chimonas, J. J. Cohen, J. Goldman, et al. 2006. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. Journal of the American Medical Association 295(4):429-433. Brewer, D. 1998. The effect of drug sampling policies on residents’ prescribing. Family Medi- cine 30(7):482-486. Brody, B. 2006a. Intellectual property and biotechnology: the U.S. internal experience—Part I. Kennedy Institute of Ethics Journal 16(1):1-37. Brody, B. 2006b. Intellectual property and biotechnology: the U.S. internal experience—Part II. Kennedy Institute of Ethics Journal 16(2):105-128. Brody, H. 2007. Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry. Lanham, MD: Rowman & Littlefield Publishers, Inc. Brotzman, G. L., and D. H. Mark. 1993. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. Journal of General Internal Medicine 8(3):130-134. Budiansky, S. 1983. Academic interest conflicts: laxity of Californian practice. Nature 301(5896):102. Burgers, J. S., R. Grol, N. S. Klazinga, M. Makela, and J. Zaat. 2003. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. International Journal for Quality in Health Care 15(1):31-45. Burton, T. M. 2006. Amid alarm bells, a blood substitute keeps pumping; ten in trial have heart attacks, but data aren’t published; FDA allows a new study; doctors’ pleas are ignored. Wall Street Journal, February 22, A1, A12. Business Wire. 2008. National study by PeopleMetrics Rx confirms importance of emotional connection between pharmaceutical sales reps and physicians. Business Wire, August 11. http://www.reuters.com/article/pressRelease/idUS168653+11-Aug-2008+BW20080811 (accessed September 25, 2008). Cain, D., G. Loewenstein, and D. Moore. 2005. The dirt on coming clean: the perverse effects of disclosing conflicts of interest. Journal of Legal Studies 34:1-25. Camilleri, M., G. L. Gamble, S. L. Kopecky, M. B. Wood, and M. L. Hockema. 2005. Prin- ciples and process in the development of the Mayo Clinic’s individual and institutional conflict of interest policy. Mayo Clinic Proceedings 80(10):1340-1346. Campbell, E. G., and D. Blumenthal. 2000. Academic industry relationships in biotechnology: a primer on policy and practice. Cloning 2(3):129-136. Campbell, E. G., K. S. Louis, and D. Blumenthal. 1998. Looking a gift horse in the mouth: corporate gifts supporting life sciences research. Journal of the American Medical As- sociation 279(13):995-999. Campbell, E. G., B. R. Clarridge, M. Gokhale, L. Birenbaum, S. Hilgartner, N. A. Holtzman, and D. Blumenthal. 2002. Data withholding in academic genetics: evidence from a na- tional survey. Journal of the American Medical Association 287(4):473-480.

OCR for page 240
 CONFLICT OF INTEREST Campbell, E. G., J. B. Powers, D. Blumenthal, and B. Biles. 2004. Inside the triple helix: tech- nology transfer and commercialization in the life sciences. Health Affairs 23(1):64-76. Campbell, E. G., J. S. Weissman, C. Vogeli, B. R. Clarridge, M. Abraham, J. E. Marder, and G. Koski. 2006. Financial relationships between institutional review board members and industry. New England Journal of Medicine 355(22):2321-2329. Campbell, E. G., R. L. Gruen, J. Mountford, L. G. Miller, P. D. Cleary, and D. Blumenthal. 2007a. A national survey of physician-industry relationships. New England Journal of Medicine 356(17):1742-1750. Campbell, E. G., J. S. Weissman, S. Ehringhaus, S. R. Rao, B. Moy, S. Feibelmann, and Susan Dorr Goold. 2007b. Institutional academic-industry relationships. Journal of the Ameri- can Medical Association 298(15):1779-1786. Campbell, S. M., M. Hann, M. O. Roland, J. A. Quayle, and P. G. Shekelle. 1999. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Medical Care 37(9):964-968. Campbell, W. A. 2007. The high cost of free lunch. Obstetrics and Gynecology 110(4):931- 932; author reply 932-933. Caplan, R. M. 1996. History of the Society of Medical College Directors of Continuing Medi- cal Education (SMCDCME): the first twelve years, 1976-1988. The Journal of Continu- ing Education in the Health Professions 16:14-24. Carlat, D. 2007. Dr. Drug Rep. The New York Times, November 25, Sec. 6, p. 64. Carlson, G. A., P. S. Jensen, R. L. Findling, R. E. Meyer, J. Calabrese, M. P. DelBello, G. Emslie, et al. 2003. Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. Journal of Child and Adolescent Psychopharmacology 13(1):13-27. Carpenter, D. In press. The ambiguous emergence of an organizational identity: pharmaceuti- cal regulation at the FDA, 1947-1961. In Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA, edited by D. Carpenter. Princeton, NJ: Princeton University Press. http://www.fas.harvard.edu/~polecon/EmergenceofAmerican PharmceuticalRegulation.pdf (accessed February 10, 2009). Carroll, A. E., R. C. Vreeman, J. Buddenbaum, and T. S. Inui. 2007. To what extent do educa- tional interventions impact medical trainees’ attitudes and behaviors regarding industry- trainee and industry-physician relationships? Pediatrics 120(6):e1528-e1535. Cassell, G. 2008. Untitled. Presentation for Eli Lilly and Company to the Institute of Medi- cine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Cates, J. R., D. N. Young, D. S. Bowerman, and R. C. Porter. 2006. An independent AGREE evaluation of the Occupational Medicine Practice Guidelines. The Spine Journal 6(1): 72-77. CBO (Congressional Budget Office). 1986. Physician Reimbursement Under Medicare: Op- tions for Change. Washington, DC: CBO. http://www.cbo.gov/ftpdocs/59xx/doc5967/ doc13b-Entire.pdf (accessed September 25, 2008). CBO. 2007. Research on the Comparatie Effectieness of Medical Treatments: Options for an Expanded Federal Role. Testimony by Director Peter R. Orszag before the House Ways and Means Subcommittee on Health, June 12. http://www.cbo.gov/ftpdocs/82xx/ doc8209/Comparative_Testimony.pdf. Cech, T. R., and J. S. Leonard. 2001. Conflicts of interest—moving beyond disclosure. Science 291(5506):989. CEJA (Council on Ethical and Judicial Affairs, American Medical Association). 2008. Industry Support of Professional Education in Medicine. CEJA Report 1-A-08. Chicago, IL: CEJA. http://www.acme-assn.org/advocacy_pg/ceja1.doc (accessed September 15, 2008).

OCR for page 240
 REFERENCES Chabner, B. A. 2008. Conflict of interest: in the eye of the beholder? The Oncologist 13(3): 212-213. Chaillet, N., E. Dube, M. Dugas, F. Audibert, C. Tourigny, W. D. Fraser, and A. Dumont. 2006. Evidence-based strategies for implementing guidelines in obstetrics: a systematic review. Obstetrics and Gynecology 108(5):1234-1245. Chan, A. W., A. Hrobjartsson, M. T. Haahr, P. C. Gotzsche, and D. G. Altman. 2004a. Empirical evidence for selective reporting of outcomes in randomized trials: compari- son of protocols to published articles. Journal of the American Medical Association 291(20):2457-2465. Chan, A. W., K. Krleza-Jeric, I. Schmid, and D. G. Altman. 2004b. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. Canadian Medical Association Journal 171(7):735-740. Changelian, P. S., D. Moshinsky, C. F. Kuhn, M. E. Flanagan, M. J. Munchhof, T. M. Harris, J. L. Doty, J. Sun, C. R. Kent, K. S. Magnuson, D. G. Perregaux, P. S. Sawyer, and E. M. Kudlacz. 2008. The specificity of JAK3 kinase inhibitors. Blood 111(4):2155-2157. Chapman, S. W., W. E. Dismukes, L. A. Proia, R. W. Bradsher, P. G. Pappas, M. G. Threlkeld, and C. A. Kauffman. 2008. Clinical practice guidelines for the management of blasto- mycosis: 2008 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 46(12):1801-1812. Chaudhry, S., S. Schroter, R. Smith, and J. Morris. 2002. Does declaration of compet- ing interests affect readers’ perceptions? A randomised trial. British Medical Journal 325(7377):1391-1392. Chew, L. D., T. S. O’Young, T. K. Hazlet, K. A. Bradley, C. Maynard, and D. S. Lessler. 2000. A physician survey of the effect of drug sample availability on physicians’ behavior. Journal of General Internal Medicine 15(7):478-483. Chimonas, S., T. A. Brennan, and D. J. Rothman. 2007. Physicians and drug representa- tives: exploring the dynamics of the relationship. Journal of General Internal Medicine 22(2):184-190. Chiong, W. 2003. Industry-to-physician marketing and the cost of prescription drugs. Ameri- can Journal of Bioethics 3(3):W28-W29. Cho, M. K., R. Shohara, A. Schissel, and D. Rennie. 2000. Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association 284(17):2203-2208. Choudhry, N. K., H. T. Stelfox, and A. S. Detsky. 2002. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. Journal of the American Medical Association 287(5):612-617. Chren, M. M., and C. S. Landefeld. 1994. Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. Journal of the American Medical Association 271(9):684-689. Christie, J. D., I. M. Rosen, L. M. Bellini, T. V. Inglesby, J. Lindsay, A. Alper, and D. A. Asch. 1998. Prescription drug use and self-prescription among resident physicians. Journal of the American Medical Association 280(14):1253-1255. Citron, P. 2008. Medical device considerations. Presentation to the Institute of Medicine Com- mittee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, January 21. Clamon, J. B. 2003. The search for a cure: combating the problem of conflicts of interest that currently plagues biomedical research. Iowa Law Reiew 89(1):235-271. Clancy, C. M. 2003. Back to the future. Health Affairs Suppl Web Exclusives: W3-314–W3-316.

OCR for page 240
0 CONFLICT OF INTEREST CMS (Centers for Medicare and Medicaid Services). 2006. National Coerage Determinations with Data Collection as a Condition of Coerage: Coerage with Eidence Deelopment. Baltimore, MD: CMS. http://www.cms.hhs.gov/mcd/ncpc_view_document.asp?id=8 (ac- cessed October 7, 2008). CMS. 2008. Factsheet: Physician Self-Referral and Hospital Ownership Disclosure Proisions in the IPPS FY 00 Final Rule. Baltimore, MD: CMS. http://www.Cms.Hhs.Gov/Apps/ Media/Press/Factsheet.Asp?Counter=3226&Intnumperpage=10&Checkdate=&Checkke y=&Srchtype=1&Numdays=3500&Srchopt=0&Srchdata=&Keywordtype=All&Chknew stype=6&Intpage=&Showall=&Pyear=&Year=&Desc=False&Cboorder=Date (accessed March 21, 2009). CMSS (Council of Medical Specialty Societies). 1999. Ethics Statement. Chicago, IL: CMSS. http://www.cmss.org/print.cfm?itemid=1100 (accessed November 20, 2008). CMSS. 2008. CMSS Task Force on Professionalism and Conflict of Interest in Medicine: Recommendations. Chicago, IL: CMSS. http://www.cmss.org/index.cfm?p=readmore& itemID=1358&detail=News%20Items (accessed February 26, 2009). Cochrane Collaboration. 2002. An Introduction to Meta-Analysis. Baltimore, MD: Cochrane Collaboration. http://www.cochrane-net.org/openlearning/html/mod3-2.htm (accessed March 23, 2009). Cochrane Collaboration. 2005. Glossary of Terms in the Cochrane Collaboration. Baltimore, MD: Cochrane Collaboration. http://www.cochrane.org/resources/handbook/glossary. pdf (accessed July 17, 2008). Cochrane Collaboration. 2006. Commercial Sponsorship and the Cochrane Collaboration. Baltimore, MD: Cochrane Collaboration. http://www.cochrane.org/docs/commercial- sponsorship.htm (accessed March 21, 2009). COGR (Council on Governmental Relations). 2002. Recognizing and Managing Personal Financial Conflicts of Interest. Washington, DC: COGR. http://www.cogr.edu/docs/ COIFinal.pdf (accessed September 19, 2008). COGR. 2003. Approaches to Deeloping an Institutional Conflict of Interest Policy. Wash- ington, DC: COGR. http://www.cogr.edu/files/publications_Conflicts.cfm (accessed November 11, 2008). Columbia College of Physicians and Surgeons. 2008. New Conflict of Interest Policy Re- garding Education and Clinical Care for P&S Faculty. New York: Columbia College of Physicians and Surgeons. http://www.columbia.edu/cu/administration/policylibrary/ policies/00bb9c661ce31c31011eda93ef3c0008/PS_COI_policy_2008_FINAL_ 1232028040523.pdf (accessed March 23, 2009). Columbia University. 2009. Columbia Uniersity Policy on Financial Conflicts of Interest and Research. New York: Columbia University. http://evpr.columbia.edu/files_sponsored projectprocedures/imce_shared/COI_Policy_4_3_09_new.pdf (accessed April 10, 2009). Columbia University. Undated. Responsible Conduct of Research: Conflicts of Interest. New York, NY: Columbia University. http://www.columbia.edu/ccnmtl/projects/rcr/rcr_ conflicts/ (accessed March 21, 2009). CONSORT Group. 2001. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 134(8):663-694. CONSORT Group. 2007. About CONSORT. http://www.consort-statement.org/?o=1014 (accessed September 26, 2008). Cook, D. M., E. A. Boyd, C. Grossmann, and L. A. Bero. 2007. Reporting science and conflicts of interest in the lay press. PLoS ONE 2(12):e1266. Cooper, D. S., G. M. Doherty, B. R. Haugen, R. T. Kloos, S. L. Lee, S. J. Mandel, E. L. Mazzaferri, et al. 2006a. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2):109-142.

OCR for page 240
 CONFLICT OF INTEREST Pettypiece, S. 2007. Pfizer job cuts may prompt Glaxo, Sanofi to follow. Bloomberg Online News, January 23. http://www.bloomberg.com/apps/news?pid=20601087&sid=ag94zZ TfJ4h4&refer=home (accessed August 12, 2008). Pfizer. 2008. Pfizer Changes Its Funding of Continuing Medical Education in the U.S. New York, NY: Pfizer. https://www.pfizermededgrants.com/pfizercme/help/CME_Funding_ Change_Announcement.html (accessed November 5, 2008). Pham, H. H., and P. B. Ginsburg. 2007. Unhealthy trends: the future of physician services. Health Affairs 26(6):1586-1598. Pham, H. H., K. J. Devers, J. H. May, and R. Berenson. 2004. Financial pressures spur physi- cian entrepreneurialism. Health Affairs 23(2):70-81. PhRMA (Pharmaceutical Research and Manufacturers of America). 2008. Code on Interac- tions with Healthcare Professionals. Washington, DC: PhRMA. http://www.phrma.org/ files/PhRMA%20Marketing%20Code%202008.pdf (accessed August 1, 2008). Piwowar, H. A., and W. W. Chapman. 2008. A review of journal policies for sharing research data. Proceedings of the ELPUB 2008 Conference on Electronic Publishing, Toronto, On- tario, Canada, June 2008. http://elpub.scix.net/data/works/att/001_elpub2008.content. pdf (accessed October 10, 2008). Plint, A., D. Moher, K. Schulz, D. Altman, and A. Morrison. 2005. Does the CONSORT checklist improe the quality of reports of randomized controlled trials? A systematic reiew. Paper presented at the Fifth International Congress on Peer Review and Biomedi- cal Publication, Chicago, IL, September 16-18. Podolsky, S. H., and J. A. Greene. 2008. A historical perspective of pharmaceutical promo- tion and physician education. Journal of the American Medical Association 300(7): 831-833. Poitras, S., J. Avouac, M. Rossignol, B. Avouac, C. Cedraschi, M. Nordin, C. Rousseaux, et al. 2007. A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria. Arthritis Research & Therapy 9(6):R126. PPRC (Physician Payment Review Commission). 1987. Medicare Physician Payment: An Agenda for Reform: Annual Report to Congress, . Washington, DC: PPRC. Pritchard, M. S. 1996. Conflicts of interest: conceptual and normative issues. Academic Medi- cine 71(12):1305-1313. Psaty, B. M., and R. A. Kronmal. 2008. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. Journal of the American Medical Association 299(15):1813-1817. Psaty, B. M., and D. Rennie. 2006. Clinical trial investigators and their prescribing patterns: another dimension to the relationship between physician investigators and the pharma- ceutical industry. Journal of the American Medical Association 295(23):2787-2790. Radek, K. A., L. A. Baer, J. Eckhardt, L. A. DiPietro, and C. E. Wade. 2008. Mechanical unloading impairs keratinocyte migration and angiogenesis during cutaneous wound healing. Journal of Applied Physiology 104(5):1295-1303. Randall, D. A. 2007. The high cost of free lunch. Obstetrics and Gynecology 110(4):932; author reply 932-933. Rapp, K. 2003. New Times, New Ethical Standards: AdaMed’s Reised Code Updates Medtech Business Practices to Meet Modern Demands for Ethical Conduct and Social Responsibility. http://www.devicelink.com/mx/archive/03/11/rapp.html (accessed March 10, 2009). Ratanawongsa, N., A. Teherani, and K. E. Hauer. 2005. Third-year medical students’ experi- experi- ences with dying patients during the internal medicine clerkship: a qualitative study of the informal curriculum. Academic Medicine 80(7):641-647.

OCR for page 240
 REFERENCES Read, J. L., and P. M. Campbell. 1988. Health care innovation: a progress report. Health Affairs 7(3):174-185. Read, J. L., and K. B. Lee, Jr. 1994. Health care innovation: progress report and focus on biotechnology. Health Affairs 13(3):215-225. Reck, J. 2008. A Template for Establishing and Administering Prescriber Support and Edu- cation Programs: A Collaboratie, Serice Based Approach for Achieing Maximum Impact. Hallowell, ME: Prescription Policy Choices. http://www.policychoices.org/ documents/AcademicDetailingTemplate.pdf (accessed October 29, 2008). Relman, A. S. 1984. Dealing with conflicts of interest. New England Journal of Medicine 310(18):1182-1183. Relman, A. S. 2001. Separating continuing medical education from pharmaceutical marketing. Journal of the American Medical Association 285(15):2009-2012. Relman, A. S. 2003. Defending professional independence: ACCME’s proposed new guide- lines for commercial support of CME. Journal of the American Medical Association 289(18):2418-2420. Relman, A. S. 2008. Industry support of medical education. Journal of the American Medical Association 300(9):1071-1073. Renfrew, M. J., L. Dyson, G. Herbert, A. McFadden, F. McCormick, J. Thomas, and H. Spiby. 2008. Developing evidence-based recommendations in public health—incorporating the views of practitioners, service users and user representatives. Health Expect 11(1):3-15. Rennie, D. 1997. Thyroid storm. Journal of the American Medical Association 277(15): 1238-1243. Rennie, D., V. Yank, and L. Emanuel. 1997. When authorship fails. A proposal to make con- tributors accountable. Journal of the American Medical Association 278(7):579-585. Rettig, R. 1997. Health Care in Transition: Technology Assessment in the Priate Sector. Santa Monica, CA: RAND. Rice, T. 1997. Physician payment policies: impacts and implications. Annual Reiew of Public Health 18:549-565. Rick, S., and G. Loewenstein. 2008. Intangibility in intertemporal choice. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 363(1511): 3813-3824. Ridgeway, J. 1968. The Closed Corporation: American Uniersities in Crisis. New York: Random House. Riechelmann, R. P., L. Wang, A. O’Carroll, and M. K. Krzyzanowska. 2007. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. Journal of Clinical Oncology 25(29):4642-4647. Rising, K., P. Bacchetti, and L. Bero. 2008. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Medicine 5(11):1561-1570. Rochon, P. A., J. H. Gurwitz, C. M. Cheung, J. A. Hayes, and T. C. Chalmers. 1994. Evaluat- ing the quality of articles published in journal supplements compared with the quality of those published in the parent journal. Journal of the American Medical Association 272(2):108-113. Rockhold, F. W., and S. Snapinn. 2007. Improving the image of pharmaceutical industry research: transparency is not always clear. Biopharmaceutical Report 15(1):2-12. http:// www.amstat.org/sections/sbiop/br_winter07.pdf (accessed February 22, 2009). Rodwin, M. 1996. Physicians’ conflicts of interest in HMOs and hospitals. In Conflicts of Interest in Clinical Practice and Research, edited by R. G. Spece, D. S. Shimm, and A. E. Buchanan. New York: Oxford University Press. Rose, J. 2008. Industry influence in the creation of pay-for-performance quality measures. Quality Management in Health Care 17(1):27-34.

OCR for page 240
6 CONFLICT OF INTEREST Rosenthal, E. 2008. Drug makers’ push leads to vaccines’ fast rise. The New York Times, August 20, A1. Rosenthal, M. B., B. E. Landon, K. Howitt, H. R. Song, and A. M. Epstein. 2007. Climbing up the pay-for-performance learning curve: where are the early adopters now? Health Affairs 26(6):1674-1682. Ross, J. S., P. Lurie, and S. M. Wolfe. 2000. Medical Education Serices Suppliers: A Threat to Physician Education. Washington, DC: Public Citizen. http://take-back-the-power. org/publications/release.cfm?ID=7142 (accessed October 10, 2008). Ross, J. S., J. E. Lackner, P. Lurie, C. P. Gross, S. Wolfe, and H. M. Krumholz. 2007. Pharmaceu- tical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. Journal of the American Medical Association 297(11):1216-1223. Ross, J. S., K. P. Hill, D. S. Egilman, and H. M. Krumholz. 2008. Guest authorship and ghost- writing in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. Journal of the American Medical Association 299(15):1800-1812. Rothman, K. J. 2001. My actual beliefs. Journal of Clinical Epidemiology 54(12):1275; author reply 1276-1277. Roughead, E. E., K. J. Harvey, and A. L. Gilbert. 1998. Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Australian and New Zealand Journal of Medicine 28(3):306-310. Sackett, D., S. Straus, S. Richardson, W. Rosenberg, and R. B. Haynes. 2000. Eidence- Based Medicine: How to Practice and Teach EBM (2nd edition). London: Churchill Livingstone. SACME (Society for Academic Continuing Medical Education). 2007. Surey for 006: Descriptie Results. SACME Biennial Survey, January. Birmingham, AL: SACME. http:// www.sacme.org/site/sacme/assets/pdf/BS_results_2006.pdf (accessed October 10, 2008). SACME. 2008a. About Us. Birmingham, AL: SACME. http://www.sacme.org/index.cfm?usec ookieval=false&pagepath=About_Us&id=1017 (accessed November 21, 2008). SACME. 2008b. SACME Response to ACCME Call for Comment on Limiting Interac- tions Between Accredited Proiders and Commercial Interests oer Commercial Support with Industry. Birmingham, AL: SACME. http://www.sacme.org/site/sacme/assets/pdf/ SACME_Response_to_ACCME_Calls_for_Comment_9-2008.pdf (accessed December 2, 2008). Sade, R. M. 2007. A national survey of physician-industry relationships. New England Journal of Medicine 357(5):507; author reply 508. Sadek, H., and Z. Henderson. 2004. It’s all in the details: delivering the right informa- tion to the right rep at the right time can greatly increase sales force effectiveness. Pharmaceutical Executie, October. http://www.imshealth.com/vgn/images/portal/cit_ 40000873/2/10/71263609PE_All_in_the_Details.pdf (accessed June 27, 2007). Sage, W. M. 2007. Some principles require principals: why banning “conflicts of interest” won’t solve incentive problems in biomedical research. Texas Law Reiew 85:1413-1463. Sagsveen, M. G. 2008. Untitled. Presentation for the American Academy of Neurology to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Salsberg, E. 2008. Addressing healthcare workforce issues for the future. Statement before the Committee on Health, Education, Labor, and Pensions (HELP), U.S. Senate, February 12. http://www.aamc.org/advocacy/library/workforce/testimony/2008/021208.pdf (ac- cessed April 10, 2009). Sampat, B. N. 2006. Patenting and US academic research in the 20th century: the world before and after Bayh-Dole. Research Policy 35(6):772-789.

OCR for page 240
 REFERENCES San Miguel, J. F., R. Schlag, N. K. Khuageva, M. A. Dimopoulos, O. Shpilberg, M. Kropff, I. Spicka, et al. 2008. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. New England Journal of Medicine 359(9):906-917. Sawka, A. M., and L. Thabane. 2003. Effect of industry sponsorship on the results of biomedi- cal research. Journal of the American Medical Association 289(19):2502-2503; author reply 2503. Schacht, W. H. 2008. The Bayh-Dole Act: Selected Issues in Patent Policy and the Commer- cialization of Technology. CRS Report for Congress, Order Code RL32076. Washington, DC: Congressional Research Service. http://assets.opencrs.com/rpts/RL32076_20080403. pdf (accessed December 15, 2008). Schneider, C., and A. Young. 2008. Emory puts heat on researcher. The Atlanta Journal- Constitution, October 5, A1. Schneider, J. A., V. Arora, K. Kasza, R. Van Harrison, and H. Humphrey. 2006. Residents’ perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Academic Medicine 81(7):595-602. Schroter, S., J. Morris, S. Chaudhry, R. Smith, and H. Barratt. 2004. Does the type of com- peting interest statement affect readers’ perceptions of the credibility of research? Ran- domised trial. British Medical Journal 328(7442):742-743. Schünemann, H. 2008. Systematic reviews and other strategies to protect against bias in guide- lines development. Presentation to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, May 22. Schünemann, H., A. Fretheim, and A. D. Oxman. 2006. Improving the use of research evi- dence in guideline development. 1. Guidelines for guidelines. Health Research Policy and Systems 4:13. Schwartz, L., S. Woloshin, and R. Moynihan. 2008. Who’s watching the watch dogs? British Medical Journal (Clinical Research Edition) 337:a2535. Schwitzer, G., G. Mudur, D. Henry, A. Wilson, M. Goozner, M. Simbra, M. Sweet, and K. A. Baverstock. 2005. What are the roles and responsibilities of the media in disseminating health information? PLoS Medicine 2(7):e215. Seidenberg, R. 1971. Advertising and abuse of drugs. New England Journal of Medicine 284(14):789-790. Severinghaus, J. W. 2007. Takuo Aoyagi: discovery of pulse oximetry. Anesthesia and Anal- gesia 105(6 Suppl.):S1-S4, table of contents. SGIM (Society of General and Internal Medicine). 2006. Policy on Acceptance and Dis- closure of External Funds. Washington, DC: SGIM. http://www.sgim.org/userfiles/file/ SocietyInfo/ExternalFundsPolicyJan2006.pdf (accessed December 15, 2008). Shaneyfelt, T. M., M. F. Mayo-Smith, and J. Rothwangl. 1999. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. Journal of the American Medical Association 281(20):1900-1905. Shapiro, D. 2004. Drug companies get too close for med school’s comfort. The New York Times, January 20, F5. Shea, B. J., J. M. Grimshaw, G. A. Wells, M. Boers, N. Andersson, C. Hamel, A. C. Porter, et al. 2007. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 7:10. Shekelle, P. G., S. H. Woolf, M. Eccles, and J. Grimshaw. 1999. Clinical guidelines: developing guidelines. British Medical Journal 318(7183):593-596. Shelton, S. 2008. Emory will punish psychiatrist Nemeroff: chairmanship taken away, outside income to be vetted. The Atlanta Journal-Constitution, December 23, Metro News, 4B. http://www.ajc.com/services/content/printedition/2008/12/23/nemeroff.html (accessed February 19, 2009).

OCR for page 240
 CONFLICT OF INTEREST Sherman, T. 2008. Cardiologist will settle fraud case: UMDNJ gave him job for referring patients. The Star-Ledger, July 1, p. 16. Shiffman, R. N., P. Shekelle, J. M. Overhage, J. Slutsky, J. Grimshaw, and A. M. Deshpande. 2003. Standardized reporting of clinical practice guidelines: a proposal from the Confer- ence on Guideline Standardization. Annals of Internal Medicine 139(6):493-498. Shuchman, M. 2007. Commercializing clinical trials—risks and benefits of the CRO boom. New England Journal of Medicine 357(14):1365-1368. Sierles, F. S., A. C. Brodkey, L. M. Cleary, F. A. McCurdy, M. Mintz, J. Frank, D. J. Lynn, et al. 2005. Medical students’ exposure to and attitudes about drug company interactions: a national survey. Journal of the American Medical Association 294(9):1034-1042. Sigworth, S. K., M. D. Nettleman, and G. M. Cohen. 2001. Pharmaceutical branding of resi- dent physicians. Journal of the American Medical Association 286(9):1024-1025. Silverstein, F. E., G. Faich, J. L. Goldstein, L. S. Simon, T. Pincus, A. Whelton, R. Makuch, et al. 2000. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-Term Arthritis Safety Study. Journal of the American Medical As- sociation 284(10):1247-1255. Simon, S. R., S. R. Majumdar, L. A. Prosser, S. Salem-Schatz, C. Warner, K. Kleinman, I. Miroshnik, et al. 2005. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. American Journal of Medicine 118(5):521-528. Sismondo, S. 2008. Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemporary Clinical Trials 29(2):109-113. Sloan, F. A., J. R. Rattliff, and M. A. Hall. 2007. Effects of state managed care patient protec- tion laws on physician satisfaction. Medical Care Research and Reiew 64(5):585-599. Smith, D. 1992. Paying for Medicare: The Politics of Reform. New York: Aldine de Gruyter. Smith, S. 2006. Article urging heart exams shows conflicting interests. Boston Globe, July 25, A1. Smulders, Y. M., and A. Thijs. 2007. The influence of the pharmaceutical industry on treatment guidelines. Nederlands Tijdschrift oor Geneeskunde 151(44):2429-2431. (In Dutch.) Snyder, L., and C. Leffler. 2005. Ethics manual: fifth edition. Annals of Internal Medicine 142(7):560-582. Sollitto, S., S. Hoffman, M. Mehlman, R. J. Lederman, S. J. Youngner, and M. M. Lederman. 2003. Intrinsic conflicts of interest in clinical research: a need for disclosure. Kennedy Institute of Ethics Journal 13(2):83-91. Solomon, D. H., L. Van Houten, R. J. Glynn, L. Baden, K. Curtis, H. Schrager, and J. Avorn. 2001. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Archies of Internal Medicine 161(15):1897-1902. Sorrell, W. H. 2008. Pharmaceutical Marketing Disclosures: Report of Vermont Attorney General William H. Sorrell on Payments to Physicians. Montpelier, VT: Vermont Office of the Attorney General. http://www.atg.state.vt.us/upload/1215544954_2008_Pharma- ceutical_Marketing_Disclosures_Report.pdf (accessed September 17, 2008). Soumerai, S. B., and J. Avorn. 1990. Principles of educational outreach (“academic detail- ing”) to improve clinical decision making. Journal of the American Medical Association 263(4):549-556. Sox, H. C., and D. Rennie. 2008. Seeding trials: just say “no.” Annals of Internal Medicine 149(4):279-280. Stanczyk, J., C. Ospelt, and S. Gay. 2008. Is there a future for small molecule drugs in the treatment of rheumatic diseases? Current Opinion in Rheumatology 20(3):257-262. Stanford University. Undated. Stanford Research Administration: Conflict of Interest. http:// dor.stanford.edu/Resources/coi.html (accessed March 21, 2009).

OCR for page 240
 REFERENCES Stanford University School of Medicine. 2006. Stanford Industry Interactions Policy. http:// med.stanford.edu/coi/siip/documents/siip_policy_aug06.pdf (accessed September 15, 2008). Stanford University School of Medicine. 2008. Continuing Medical Education (CME) Com- mercial Support Policy. http://cme.stanford.edu/documents/cme_commercial_support_ policy.pdf (accessed September 15, 2008). Stark, A. 2000. Conflict of Interest in American Public Life. Cambridge, MA: Harvard Uni- versity Press. Steinberg, E. P., and B. R. Luce. 2005. Evidence based? Caveat emptor�� Health Affairs 24(1):80-92. Steinbrook, R. 2005. Commercial support and continuing medical education. New England Journal of Medicine 352(6):534-535. Steinbrook, R. 2006. For sale: physicians’ prescribing data. New England Journal of Medicine 354(26):2745-2747. Steinbrook, R. 2007. Guidance for guidelines. New England Journal of Medicine 356(4): 331-333. Steinbrook, R. 2008a. Disclosure of industry payments to physicians. New England Journal of Medicine 359(6):559-561. Steinbrook, R. 2008b. Financial support of continuing medical education. Journal of the American Medical Association 299(9):1060-1062. Steinbrook, R. 2008c. The Gelsinger case. In The Oxford Textbook of Clinical Research Eth- ics, edited by E. J. Emanuel, C. Grady, R. A. Crouch, R. Lie, F. Miller and D. Wendler. New York: Oxford University Press. Steinman, M. A. 2008. Conflict of interest in graduate and undergraduate medical education. Presentation to the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education, and Practice, Washington, DC, January 21. Steinman, M. A., M. G. Shlipak, and S. J. McPhee. 2001. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. American Journal of Medicine 110(7):551-557. Steinman, M. A., L. A. Bero, M. M. Chren, and C. S. Landefeld. 2006. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Annals of Internal Medicine 145(4):284-293. Steinman, M. A., G. M. Harper, M. M. Chren, C. S. Landefeld, and L. A. Bero. 2007. Char- Char- acteristics and impact of drug detailing for gabapentin. PLoS Medicine 4(4):e134. Steneck, N. H. 1984. Commentary: the university and research ethics. Science, Technology, & Human Values 9(4):6-15. Stievater, D. N., A. Petersen, and R. Bhatia. 2006. Sewing up new sales. Pharmaceutical Executie, September. http://www.impactrx.com/pdfs/Sewing_Up_Sales_PharmaExec10_ 26_06.pdf (accessed August 27, 2007). Stolberg, S. G. 1999. The biotech death of Jesse Gelsinger. NYT Magazine, November 28, pp. 136-140, 149-150. Stolberg, S. G. 2000. Biomedicine is receiving new scrutiny as scientists become entrepreneurs. The New York Times, February 20, Sec. 1, p. 26. Stossel, T. P. 2005. Regulating academic-industrial research relationships—solving problems or stifling progress? New England Journal of Medicine 353(10):1060-1065. Stossel, T. P. 2007. Regulation of financial conflicts of interest in medical practice and medi- cal research: a damaging solution in search of a problem. Perspecties in Biology and Medicine 50(1):54-71. Stossel, T. P. 2008. Has the hunt for conflicts of interest gone too far? Yes. British Medical Journal 336(7642):476. Stotland, N. 2008. APA responds to Sen. Grassley. Psychiatric News 43(17):3.

OCR for page 240
0 CONFLICT OF INTEREST Streiffer, R. 2006. Academic freedom and academic-industry relationships in biotechnology. Kennedy Institute of Ethics Journal 16(2):129-149. Stroup, D. F., J. A. Berlin, S. C. Morton, I. Olkin, G. D. Williamson, D. Rennie, D. Moher, et al. 2000. Meta-analysis of observational studies in epidemiology: a proposal for report- ing. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association 283(15):2008-2012. Studdert, D. M., M. M. Mello, and T. A. Brennan. 2004. Financial conflicts of interest in physicians’ relationships with the pharmaceutical industry—self-regulation in the shadow of federal prosecution. New England Journal of Medicine 351(18):1891-1900. Sulmasy, D. P., M. G. Bloche, J. M. Mitchell, and J. Hadley. 2000. Physicians’ ethical beliefs about cost-control arrangements. Archies of Internal Medicine 160(5):649-657. Suwa, K. 2003. Pulse oximeters: personal recollections of the past and hopes for the future. Journal of Anesthesia 17(4):267-269. Swann, J. P. 1988. Academic Scientists and the Pharmaceutical Industry. Baltimore, MD: The Johns Hopkins University Press. Symm, B., M. Averitt, S. N. Forjuoh, and C. Preece. 2006. Effects of using free sample medica- tions on the prescribing practices of family physicians. Journal of the American Board of Family Medicine 19(5):443-449. Takhar, J., D. Dixon, J. Donahue, B. Marlow, C. Campbell, I. Silver, J. Eadie, et al. 2007. Developing an instrument to measure bias in CME. Journal of Continuing Education in the Health Professions 27(2):118-123. Tanaka, M., and S. Watanabe. 1994. Overwintering in the Antarctica as an analog for long term manned spaceflight. Adances in Space Research 14(8):423-430. Tcheng, J. E., D. E. Kandzari, C. L. Grines, D. A. Cox, M. B. Effron, E. Garcia, J. J. Griffin, et al. 2003. Benefits and risks of abciximab use in primary angioplasty for acute myo- cardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 108(11):1316-1323. Tenaglia, M., and P. Angelastro. 2005. No margin for error. Pharmaceutical Executie, Sep- tember. http://www.amundsengroup.com/images/nomarginforerror.pdf (accessed August 27, 2007). Tereskerz, P. M., and J. Moreno. 2005. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Accountability in Research 12(2):139-155. Thayer, A. 2005. Insulin: in Top Pharmaceuticals: a look at drugs that changed the world. Chemical & Engineering News 83(25):3. Thompson, D. F. 1993. Understanding financial conflicts of interest. New England Journal of Medicine 329(8):573-576. Thrasher, K., and M. Franklin. 1999. Minnesota sets the pace: medical technology started with a pacemaker. Minnesota Technolog, November/December. http://technolog.it.umn. edu/technolog/novdec99/pacemaker.html (accessed July 15, 2008). Tovino, S. A. 2007. Functional neuroimaging and the law: trends and directions for future scholarship. American Journal of Bioethics 7(9):44-56. Trachtman, H. 2003. The death of common sense. American Journal of Bioethics 3(3): W31-W32. Tregear, M. 2007. Guideline Heterogeneity. Workshop—Part 2, ECRI Institute, August 27 Presentation at the Fourth Annual Guidelines International Network Meeting, Toronto on August 22-25. Tu, H. T., and P. B. Ginsburg. 2006. Losing Ground: Physician Income, -00. Tracking Report 15. Washington, DC: Center for Studying Health System Change, pp. 1-8.

OCR for page 240
 REFERENCES Tunis, S. R., D. B. Stryer, and C. M. Clancy. 2003. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290(12):1624-1632. Turner, E. H., A. M. Matthews, E. Linardatos, R. A. Tell, and R. Rosenthal. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358(3):252-260. Turton, F. E., and L. Snyder. 2007. Physician-industry relations. Annals of Internal Medicine 146(6):469. Ubel, P. A., R. M. Arnold, G. P. Gramelspacher, R. B. Hoppe, C. S. Landefeld, W. Levinson, W. Tierney, and S. W. Tolle. 1995. Acceptance of external funds by physician organizations: issues and policy options. Journal of General Internal Medicine 10(11):624-630. Ubel, P. A., C. Jepson, and D. A. Asch. 2003. Misperceptions about beta-blockers and diuret- ics: a national survey of primary care physicians. Journal of General Internal Medicine 18(12):977-983. University of California. 2008. Health Care Vendor Relations Policy. Oakland, CA: University of California. http://www.ucop.edu/ucophome/coordrev/policy/PP031208Policy.pdf (ac- cessed December 12, 2008). University of Louisville. 2008. Uniersity of Louisille Health Care Policy on Vendors. Louisville, KY: University of Louisville. http://louisville.edu/medschool/dean/docs/ VendorPolicy%20Approved.pdf (accessed December 31, 2008). University of Massachusetts. 2008. Vendor Relations Policy Frequently Asked Questions (FAQs). http://www.amsascorecard.org/documents/0000/0027/FAQs_UMM_Policy_2- 2008.doc (accessed December 31, 2008). University of Michigan. 2005. Conflicts of Interest and Conflicts of Commitment. Standard Practice Guide (Number 201.65-1). Ann Arbor: University of Michigan. http://spg.umich. edu/pdf/201.65-1.pdf (accessed July 11, 2008). University of Michigan Health System. 2007. UMHHC Policy 0-0-0: Drug Samples in UMHHC. Ann Arbor: University of Michigan Health System. http://www.imapny.org/ usr_doc/Drug_Sample_PolicyM4.pdf (accessed October 7, 2008). University of Minnesota. 2008. Potential Conflicts of Interest: A Course for Uniersity of Minnesota Researchers. St. Paul, MN: University of Minnesota. http://cflegacy.research. umn.edu/coi/index.shtml (accessed March 21, 2009). University of Pittsburgh. 2007. Industry Interactions Policy. Pittsburgh, PA: University of Pittsburgh. http://www.ogc.pitt.edu/publications/IndustryRelationshipsPolicy.pdf (ac - cessed October 7, 2008). University of Rochester. 2006. Uniersity of Rochester Policy on Institutional Conflict of Inter- est in Research Actiities. Rochester, NY: University of Rochester. http://www.rochester. edu/ORPA/policies/COIresearch.pdf (accessed January 13, 2009). University of Washington. 2008. State Ethics Act of 00—Impact on UW Policy. Seattle: Univer- sity of Washington. http://www.washington.edu/research/main.php?page=stateEthicsAct (accessed October 21, 2008). University of Wisconsin. 2008. Showcase: Campus-Wide Change Efforts. Madison: University of Wisconsin. http://www.oqi.wisc.edu/Showcase/Portals/0/CampusWideChange.pdf (ac - cessed January 13, 2009). USPHS (U.S. Public Health Service Commissioned Corps). 1995. Objectivity in research; final rule. Federal Register 60(132):35810-35819. USPSTF (U.S. Preventive Services Task Force). 2007a. Screening for lipid disorders in chil- dren: U.S. Preventive Services Task Force recommendation statement. Pediatrics 120(1): e215-e219.

OCR for page 240
 CONFLICT OF INTEREST USPSTF. 2007b. Screening for Lipid Disorders in Children: U.S. Preentie Serices Task Force Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/uspstf07/chlipid/chlipidrs.htm (accessed March 21, 2009). USPSTF. 2007c. Screening for Sickle Cell Disease in Newborns: U.S. Preentie Serices Task Force Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/uspstf07/sicklecell/sicklers.htm (accessed April 25, 2008). USPSTF. 2008. Methods and Background: U.S. Preentie Serices Task Force. Rockville, MD: Agency for Healthcare Research and Quality. http://www.ahrq.gov/clinic/uspstf08/ methods/procmanual.htm (accessed April 10, 2009). van Eijk, M. E., J. Avorn, A. J. Porsius, and A. de Boer. 2001. Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus indi- vidual academic detailing. British Medical Journal 322(7287):654-657. Varley, C. K., M. D. Jibson, M. McCarthy, and S. Benjamin. 2005. A survey of the interac- tions between psychiatry residency programs and the pharmaceutical industry. Academic Psychiatry 29(1):40-46. Verkerk, K., H. Van Veenendaal, J. L. Severens, E. J. Hendriks, and J. S. Burgers. 2006. Con-Con- sidered judgement in evidence-based guideline development. International Journal for Quality in Health Care 18(5):365-369. Vesely, R. 2005. Kaiser doctors conflict-of-interest policy tightened. Oakland Tribune, April 27. Vogeli, C., R. Yucel, E. Bendavid, L. M. Jones, M. S. Anderson, K. S. Louis, and E. G. Campbell. 2006. Data withholding and the next generation of scientists: results of a national survey. Academic Medicine 81(2):128-136. von Elm, E., D. G. Altman, M. Egger, S. J. Pocock, P. C. Gotzsche, and J. P. Vandenbroucke. 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Medicine 4(10):e296. Vreman, H. J., R. J. Wong, J. R. Murdock, and D. K. Stevenson. 2008. Standardized bench method for evaluating the efficacy of phototherapy devices. Acta Paediatrica 97(3): 308-316. Wager, E. 2007. Authors, ghosts, damned lies, and statisticians. PLoS Medicine 4(1): e34-e35. Walker, L. 2001. ROI for Meetings Beats Detailing and DTC. http://meetingsnet.com/medi- calmeetings/meetings_roi_meetings_beats/ (accessed September 25, 2008). Wall, L. L., and D. Brown. 2007. The high cost of free lunch. Obstetrics and Gynecology 110(1):169-173. Wallack, T. 2008. Tied up over disclosure: life sciences firms anxious about rules on gifts to doctors. The Boston Globe, August 13, C1. WAME (World Association of Medical Editors). 2008. WAME Recommendations on Publica- tion Ethics Policies for Medical Journals. http://www.wame.org/resources/publication- ethics-policies-for-medical-journals#conflicts (accessed December 2, 2008). Warlow, C. 2007. No ghosts here please. Practical Neurology 7(2):72-73. Warner, T. D., and J. P. Gluck. 2003. What do we really know about conflicts of interest in biomedical research? Psychopharmacology 171(1):36-46. Warner, T. D., and L. W. Roberts. 2004. Scientific integrity, fidelity and conflicts of interest in research. Current Opinion in Psychiatry 17:381-385. Wartman, S. A. 2007. The Academic Health Center: Eoling Organizational Models. Wash- ington, DC: Association of Academic Health Centers. http://www.aahcdc.org/policy/ reddot/AAHC_Evolving_Organizational_Models.pdf (accessed August 12, 2008).

OCR for page 240
 REFERENCES Waters, R. 2006. J&J sued by Texas in whistleblower case on marketing (update1). Bloomberg Online News, December 28. http://www.bloomberg.com/apps/news?pid=20601202&sid =a2mpCNBojB2I&refer=healthcare (accessed April 25, 2008). Watson, P. Y., A. K. Khandelwal, J. L. Musial, and J. D. Buckley. 2005. Resident and faculty perceptions of conflict of interest in medical education. Journal of General Internal Medicine 20(4):357-359. Weber, M. 2006. Medicine and Conflicts of Interest: Creating a New Morality. http://www. medicalprogresstoday.com/spotlight/spotlight_indarchive.php?id=1399 (accessed Octo - ber 10, 2008). Wegman, A., D. van der Windt, M. van Tulder, W. Stalman, and T. de Vries. 2004. Nonste- roidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. Journal of Rheumatology 31(2):344-354. Weinfurt, K. P., J. Y. Friedman, J. S. Allsbrook, M. A. Dinan, M. A. Hall, and J. Sugarman. 2006a. Views of potential research participants on financial conflicts of interest: bar- riers and opportunities for effective disclosure. Journal of General Internal Medicine 21(9):901-906. Weinfurt, K. P., M. A. Dinan, J. S. Allsbrook, J. Y. Friedman, M. A. Hall, K. A. Schulman, and J. Sugarman. 2006b. Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Academic Medicine 81(2):113-118. Weinfurt, K. P., J. Y. Friedman, M. A. Dinan, J. S. Allsbrook, M. A. Hall, J. K. Dhillon, and J. Sugarman. 2006c. Disclosing conflicts of interest in clinical research: views of institu- tional review boards, conflict of interest committees, and investigators. Journal of Law, Medicine and Ethics 34(3):581-591, 481. Weinfurt, K. P., M. A. Hall, M. A. Dinan, V. DePuy, J. Y. Friedman, J. S. Allsbrook, and J. Sugarman. 2008a. Effects of disclosing financial interests on attitudes toward clinical research. Journal of General Internal Medicine 23(6):860-866. Weinfurt, K. P., M. A. Hall, J. Y. Friedman, C. Hardy, A. K. Fortune-Greeley, J. S. Lawlor, J. S. Allsbrook, L. Lin, K. A. Schulman, and J. Sugarman. 2008b. Effects of disclosing finan- cial interests on participation in medical research: a randomized vignette trial. American Heart Journal 156(4):689-697. Weinfurt, K. P., D. M. Seils, J. P. Tzeng, L. Lin, K. A. Schulman, and R. M. Califf. 2008c. Con- sistency of financial interest disclosures in the biomedical literature: the case of coronary stents. PLoS ONE 3(5):e2128. Weinmann, S., M. Koesters, and T. Becker. 2007. Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psy- chiatrica Scandinaica 115(6):420-433. Weiss, R. 2005. NIH clears most researchers in conflict-of-interest probe. The Washington Post, February 23, A1. Wellman, H. R. 1967. Memorandum to the faculty and staff of the University of California on the university-wide statement on conflicts of interest. http://www.ucop.edu/ucophome/ coordrev/policy/10-05-67.html (accessed July 29, 2008). Wennberg, J. E. 2003. The more things change . . .: the federal government’s role in the evalu- ative sciences. Health Affairs Suppl. Web Exclusives:W3-308–W3-310. Werhane, P., and J. Doering. 1995. Conflicts of interest and conflicts of commitment. Profes- sional Ethics 4(3-4):47-81. Whelan, E. 2008. ‘Conflict’ chills research. The Washington Times, April 8, A19. Whittington, C. J., T. Kendall, P. Fonagy, D. Cottrell, A. Cotgrove, and E. Boddington. 2004. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363(9418):1341-1345. Willman, D. 2004. The National Institutes of Health: public servant or private marketer? Los Angeles Times, December 22, A1.

OCR for page 240
 CONFLICT OF INTEREST Willman, D. 2006. NIH audit criticizes scientist’s dealings. Los Angeles Times, September 10, A1. Wilson, J. W., C. M. Ott, K. Honer zu Bentrup, R. Ramamurthy, L. Quick, S. Porwollik, P. Cheng, et al. 2007. Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proceedings of the National Academy of Sciences of the United States of America 104(41):16299-16304. Wimsatt, L., A. Trice, and R. Decker. 2005. Federal Demonstration Partnership: Fall 00 Faculty Burden. http://thefdp.org/Faculty_Burden_Survey.pdf (accessed July 2, 2008). Witkin, K. B. 1997. Using pilot studies to chart a course in clinical research. Medical De- ice & Diagnostic Indaustry Magazine, June. http://www.devicelink.com/mddi/ archive/97/06/018.html (accessed March 2, 2009). WMS (Wisconsin Medical Society). 2008. Wisconsin Medical Society Board Passes New Physi- cian Gift Policy. Press release, October 16. Madison, WI: WMS. http://www.wisconsin- medicalsociety.org/publications_and_media/press_releases (accessed October 29, 2008). Woolf, S. H., R. Grol, A. Hutchinson, M. Eccles, and J. Grimshaw. 1999. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. British Medical Journal 318(7182):527-530. Woolley, K. L., J. A. Ely, M. J. Woolley, L. Findlay, F. A. Lynch, Y. Choi, and J. M. McDonald. 2006. Declaration of medical writing assistance in international peer-reviewed publica- tions. Journal of the American Medical Association 296(8):932-934. Wright, J. M., T. L. Perry, K. L. Bassett, and G. K. Chambers. 2001. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. Journal of the American Medical Associa- tion 286(19):2398-2400. Yank, V., D. Rennie, and L. A. Bero. 2007. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. British Medical Journal 335(7631):1202-1205. Zarin, D. A., T. Tse, and N. C. Ide. 2005. Trial registration at ClinicalTrials.gov between May and October 2005. New England Journal of Medicine 353(26):2779-2787. Zerhouni, E. 2007. Untitled. Presentation to the Institute of Medicine Committee on Conflicts of Interest in Medical Research, Education, and Practice, Washington, DC, November 6. Zerhouni, E. 2008. NIH response to OIG findings and recommendations. Appendix to the Office of Inspector General Report. In National Institutes of Health: Conflicts of Inter- est in Intramural Research. Bethesda, MD: National Institutes of Health. http://oig.hhs. gov/oei/reports/oei-03-06-00460.pdf (accessed June 23, 2008). Zipkin, D. A., and M. A. Steinman. 2005. Interactions between pharmaceutical representa- representa- tives and doctors in training. A thematic review. Journal of General Internal Medicine 20(8):777-786.